About: Serum fatty acid binding protein 4, free fatty acids, and metabolic risk markers

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Serum fatty acid binding protein 4, free fatty acids, and metabolic risk markers Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on July 2009

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2009 (ast) наукова стаття, опублікована в липні 2009 (uk) مقالة علمية نشرت في يوليو 2009 (ar) scientific article published on July 2009 (en)
publication date	wds:Q37289232-00882FD8-CFB7-4AF8-B645-F97A1D88AE72
publication date	2009-07-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37289232-84CB3EA0-33C4-415D-8313-553BCAA41AE6
language of work or name	English
cites work	wds:Q37289232-01288258-800F-4D8E-A20B-86D8BF6F5E8B wds:Q37289232-02038336-25F9-4E83-8604-7DA766342861 wds:Q37289232-0D2C3278-FBC1-4A97-A3EC-49FE49D81054 wds:Q37289232-1453554D-3955-4975-8DFA-634C880056EF wds:Q37289232-1BB72ECB-48D8-4C29-AB0C-CAF059984B27 wds:Q37289232-1F5181D4-1D17-43B3-8A18-BC25E3A4BBB4 wds:Q37289232-30CE336F-F4B3-41AA-B7C9-93ED6F865CD8 wds:Q37289232-3809C1FF-B1B7-4F72-9DD6-4F664FE23F4D wds:Q37289232-4995F1CC-32F7-4891-B25B-FBAC546E3CEA wds:Q37289232-4E058C0C-CAC0-4B78-9D04-1FB52E8DE93C wds:Q37289232-571EA593-CDAE-4DD7-A95A-3355AD9FEA77 wds:Q37289232-5E5F52AC-F78C-46B2-B097-49CEEF44FA7A wds:Q37289232-69ED4EBE-2657-4BE1-8A48-B2B010EDD2A7 wds:Q37289232-6EA557AA-59A2-46CF-A4B9-410F8A42AEA7 wds:Q37289232-7141E23C-BB6A-4F55-BE3A-A5985E25C55A wds:Q37289232-7C712D99-5234-4F40-921A-D05D9CCD9D07 wds:Q37289232-8AD194CD-1052-4DB3-AFF9-6853C91C16D4 wds:Q37289232-9357E49C-CF18-4293-963A-8C9BDC06BB04 wds:Q37289232-93C347AD-2C25-4A0C-A4E2-E0EA989CE779 wds:Q37289232-98E19ABB-0EFB-4E7D-A487-D652FCDBFE6D wds:Q37289232-9DA191AF-5E96-4EB4-9DC6-545E6E67085B wds:Q37289232-A06EB675-5CA1-4AC7-A931-6E2640313DCD wds:Q37289232-A1459B88-C446-455B-8626-AFAF0B16CDD5 wds:Q37289232-B5C5F6D9-0D68-42B4-AEBB-9121086DDC46 wds:Q37289232-BFAE3432-211E-41AF-A7A7-1F5FA65BDF59 wds:Q37289232-C4C6E45B-F00D-4A0E-BC12-E0903166EDB7 wds:Q37289232-DDC8598D-8159-4070-A43F-1E7A451AEF1D wds:Q37289232-E27259B7-9640-4C38-A217-E764CCA00044 wds:Q37289232-E44FFD6D-2540-48B3-B394-138E5A1B29B7 wds:Q37289232-F2B48715-6221-47A6-8B14-2FE376CB0B5F
cites work	Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2 A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Banting lecture 1988. Role of insulin resistance in human disease Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome? Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk Interaction of rat hormone-sensitive lipase with adipocyte lipid-binding protein Minimal model-based insulin sensitivity has greater heritability and a different genetic basis than homeostasis model assessment or fasting insulin Treatment with atorvastatin reduces serum adipocyte-fatty acid binding protein value in patients with hyperlipidaemia Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients. A novel minimal model to describe NEFA kinetics following an intravenous glucose challenge FFAs: do they play a role in vascular disease in the insulin resistance syndrome? Characterization of the functional interaction of adipocyte lipid-binding protein with hormone-sensitive lipase Insulin action and non-esterified fatty acids The fatty acid binding protein-4 (FABP4) is a strong biomarker of metabolic syndrome and lipodystrophy in HIV-infected patients Measurement of body composition: applications in hormone research Association of free fatty acids (FFA) and tumor necrosis factor-alpha (TNF-alpha) and insulin-resistant metabolic disorder. Blocking fatty acids' mystery tour: a therapy for metabolic syndrome? [Relations of serum adipocyte fatty acid binding protein to sex hormone and lipoproteins in patients with polycystic ovary syndrome]
author name string	wds:Q37289232-1F1E2BAF-37DC-466A-B336-FED70B88C795 wds:Q37289232-D09D9693-78BD-483F-82C8-9EC003BA6148 wds:Q37289232-EDBC7785-7BC2-43CC-9602-4E7066764727
author name string	Kyoungmi Kim Rogelio U Almario Sidika E Karakas
rdfs:label	Serum fatty acid binding protein 4, free fatty acids, and metabolic risk markers (en) Serum fatty acid binding protein 4, free fatty acids, and metabolic risk markers (nl) Serum fatty acid binding protein 4, free fatty acids, and metabolic risk markers (ast)
skos:prefLabel	Serum fatty acid binding protein 4, free fatty acids, and metabolic risk markers (en) Serum fatty acid binding protein 4, free fatty acids, and metabolic risk markers (nl) Serum fatty acid binding protein 4, free fatty acids, and metabolic risk markers (ast)
name	Serum fatty acid binding protein 4, free fatty acids, and metabolic risk markers (en) Serum fatty acid binding protein 4, free fatty acids, and metabolic risk markers (nl) Serum fatty acid binding protein 4, free fatty acids, and metabolic risk markers (ast)
title	wds:Q37289232-F7BBFC9D-DED2-4F0E-B774-9BFA8476291E
title	Serum fatty acid binding protein 4, free fatty acids, and metabolic risk markers (en)
page(s)	wds:Q37289232-35808EFC-FB64-42BC-A256-FE08DEA8672D
page(s)	1002-1007

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software